Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neo-Adjuvant Atezolizumab in Regionally Metastatic Head and Neck Cutaneous Squamous Cell Carcinoma
NCT05110781Phase 2Terminated
- Sponsor
- University of California, Davis
- Start
- Dec 2021
- Primary completion
- May 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of atezolizumab in cutaneous squamous cell carcinoma (cSCC), sponsored by University of California, Davis. Started Dec 2021; status: terminated.
02
Drugs
atezolizumab
03
Conditions
cutaneous squamous cell carcinoma (cSCC)
Beyond the preview
Go deeper on NCT05110781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05110781.